BRCA2 and breast carcinoma: As hypothesised, this population-based study in non-Asian Australian women under the age of 40 years found, with or without excluding cases known to carry a germline mutation in BRCA1 or BRCA2, no evidence that the effects of any of the major established risk factors differ for breast cancers defined by joint ER and PR status.